Dr. Hwang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
241 Sunset Rd
Skillman, NJ 08558Phone+1 415-992-6293- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Infectious Disease, 2005 - 2009
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2003 - 2005
- West Virginia University School of MedicineClass of 2003
Certifications & Licensure
- TN State Medical License 2004 - 2019
Clinical Trials
- HIV Resistance and Treatment Strategies Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- 31 citationsDoravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infecti...Chloe Orkin, Kathleen Squires, Jean-Michel Molina, Paul E. Sax, Otto Sussmann, Gina Lin, Sushma Kumar, George J. Hanna, Carey Hwang, Elizabeth Martin, Hedy Teppler> ;Clinical Infectious Diseases. 2020 Dec 18
- 6 citationsOnce-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy AnalysisChloe Orkin, Jean-Michel Molina, Johan Lombaard, Edwin DeJesus, Anthony Rodgers, Sushma Kumar, Elizabeth Martin, George J. Hanna, Carey Hwang> ;Clinical Infectious Diseases. 2020 Mar 17
- 3 citationsDoravirine exposure and HIV-1 suppression after switching from an efavirenz-based regimen to doravirine/lamivudine/tenofovir disoproxil fumarate.Wayne Greaves, Hong Wan, Ka Lai Yee, Bhargava Kandala, Pavan Vaddady, Carey Hwang> ;Antimicrobial Agents and Chemotherapy. 2019 Sep 23
- Join now to see all
Journal Articles
- Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Is Non-Inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive Adults with Human Immun...George J Hanna, Peter Sklar, Kathleen E Squires, Paul E Sax, Carey Hwang, Clinical Infectious Diseases
Press Mentions
- Vir Biotechnology Announces First Patient Dosed in the Phase 2 SOLSTICE Trial Evaluating VIR-2218 and VIR-3434 for the Treatment of Chronic Hepatitis D Virus InfectionSeptember 22nd, 2022
- Ascletis, Takeda, Arrowhead & More Present New Findings at EASL Liver ConferenceJune 27th, 2022
- Vir Biotechnology Announces New Clinical Data from Its Broad Hepatitis B ProgramJune 27th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: